Precigen (PGEN) Amortizatization of Intangibles (2013 - 2026)
Precigen's (PGEN) quarterly Amortizatization of Intangibles came in at $369000.0 in Q1 2026, down 47.73% year-on-year from $706000.0 in Q1 2025, and down 48.25% on a QoQ basis from $713000.0 in Q4 2025.
Precigen (PGEN) Amortizatization of Intangibles (2013 - 2026) Analysis & Trends
Precigen (PGEN) has 14 years of Amortizatization of Intangibles data on file, last reported at $369000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 47.73% year-over-year to $369000.0 in Q1 2026; TTM through Mar 2026 was $1.9 million, a 56.71% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, up 149.72% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $369000.0, down from $713000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for PGEN reached as high as $713000.0 in Q4 2025 and fell as low as -$265000.0 in Q1 2022.
- Historically, Amortizatization of Intangibles has averaged $260823.5 across 5 years, with a median of $318000.0 in 2025.
- Across the five-year window, Amortizatization of Intangibles plunged 364.91% in 2022 and surged 412.12% in 2023, its largest moves.
- Year by year, Amortizatization of Intangibles stood at -$165000.0 in 2022, then jumped by 412.12% to $515000.0 in 2023, then slumped by 70.68% to $151000.0 in 2024, then jumped by 372.19% to $713000.0 in 2025, then slumped by 48.25% to $369000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $369000.0 in Q1 2026, $713000.0 in Q4 2025, and $318000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Precigen | 1.95 Bn | 1.95 Bn | 20.69 Mn | 369,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 369,000.00 |
| Mar 31, 2026 | 369,000.00 |
| Dec 31, 2025 | 713,000.00 |
| Dec 31, 2025 | 713,000.00 |
| Sep 30, 2025 | 318,000.00 |
| Sep 30, 2025 | 318,000.00 |
| Jun 30, 2025 | 468,000.00 |
| Jun 30, 2025 | 468,000.00 |
| Mar 31, 2025 | 706,000.00 |
| Mar 31, 2025 | 706,000.00 |
| Dec 31, 2024 | 151,000.00 |
| Dec 31, 2024 | 151,000.00 |
| Sep 30, 2024 | 162,000.00 |
| Sep 30, 2024 | 162,000.00 |
| Jun 30, 2024 | 173,000.00 |
| Jun 30, 2024 | 173,000.00 |
| Mar 31, 2024 | 397,000.00 |
| Mar 31, 2024 | 397,000.00 |
| Dec 31, 2023 | 515,000.00 |
| Dec 31, 2023 | 515,000.00 |